Literature DB >> 6774048

Heterogeneity of human serum amyloid A proteins.

L L Bausserman, P N Herbert, K P McAdam.   

Abstract

Serum amyloid A proteins (SAA), presumed precursors of the tissue amyloid A proteins (AA) characteristic of secondary amyloidosis, have been isolated from the plasma high-density lipoproteins (HDL) of normals after etiocholanolone-induced inflammation and from patients with Wegener's granulomatosis, systemic lupus erythematosis, juvenile rheumatoid arthritis, Waldenström's macroglobulinemia, and Goodpasture's syndrome. At least six polymorphic forms of SAA wer identified among the low molecular weight proteins of HDL, and these comprosed up to 27% of the total HDL protein. Gel and ion-exchange chromatography permitted isolation of the SAA polymorphs in homogeneous form. Their amino acid compositions were very similar, they were indistinguishable in cationic and sodium dodecyl sulfate-polyacrylamide gel electrophoresis systems, and each had the terminal sequency COOH-Tyr-Lys-Phe-. Charge heterogeneity in anionic-urea polyacrylamide gel electropherograms was unaffected by neuaminidase treatment, and none of the SAA protein bands stained with the periodate-Schiff reagent. The two major SAA polymorphs, designated SAA4 and SAA5 according to their order of elution from DEAE-cellulose, had different NH2-terminal sequences. Manual Edman degradation demonstrated NH2-arg-ser-phe-phe- for SAA4 and NH2-ser-phe-phe- for SAA5. This NH2-terminal heterogeneity corresponds to that most frequently reported for AA and suggests that microheterogeneity in SAA may underlie that already documented in AA. Sufficient quantitites of the other SAA polymorphs were not available for similar analyses, but the amino acid compositions do not indicate that NH2-terminal heterogeneity accounts for all of the observed polymorphism. Artifactual polymorphism also appears unlikely, and the heterogeneiy of SAA may reflect origin from more than one cell type with or without posttranslational modificaton. We calculate from quantitative COOH-terminal analyses that SAA is of 11,000-11,900 mol wt. Primary structure studies have shown AA t be a single chain protein of 76 residues, and SAA, therefore, appears to contain a peptide of 33 amino acids that is missing from AA.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6774048      PMCID: PMC2185911          DOI: 10.1084/jem.152.3.641

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  38 in total

1.  Isolation and characterization of two threonine-poor apolipoproteins of human plasma high density lipoproteins.

Authors:  V G Shore; B Shore; S B Lewis
Journal:  Biochemistry       Date:  1978-05-30       Impact factor: 3.162

2.  Amyloid A: amphipathic helixes and lipid binding.

Authors:  J P Segrest; H J Pownall; R L Jackson; G G Glenner; P S Pollock
Journal:  Biochemistry       Date:  1976-07-27       Impact factor: 3.162

3.  Fractionation of the C-apoproteins from human plasma very low density lipoproteins.

Authors:  P N Herbert; R S Shulman; R I Levy; D S Fredrickson
Journal:  J Biol Chem       Date:  1973-07-25       Impact factor: 5.157

4.  Amino acid sequence of an amyloid fibril protein of unknown origin.

Authors:  D Ein; S Kimura; W D Terry; J Magnotta; G G Glenner
Journal:  J Biol Chem       Date:  1972-09-10       Impact factor: 5.157

5.  Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation.

Authors:  K P McAdam; R J Elin; J D Sipe; S M Wolff
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

6.  Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin.

Authors:  R P Linke; J D Sipe; P S Pollock; T F Ignaczak; G G Glenner
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

7.  Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease.

Authors:  J R Wright; E Calkins; R L Humphrey
Journal:  Lab Invest       Date:  1977-03       Impact factor: 5.662

8.  Isolation and partial characterization of SAA-an amyloid-related protein from human serum.

Authors:  C J Rosenthal; E C Franklin; B Frangione; J Greenspan
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

9.  Variation with age and disease of an amyloid A protein-related serum component.

Authors:  C J Rosenthal; E C Franklin
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

10.  Amyloid-related serum protein SAA from three animal species: comparison with human SAA.

Authors:  R F Anders; J B Natvig; K Sletten; G Husby; K Nordstoga
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

View more
  31 in total

Review 1.  New insights into the biology of the acute phase response.

Authors:  A F Suffredini; G Fantuzzi; R Badolato; J J Oppenheim; N P O'Grady
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

2.  Heterogeneity of serum amyloid A with respect to molecular mass.

Authors:  F Ogata
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

3.  Human serum amyloid A protein. Behaviour in aqueous and urea-containing solutions and antibody production.

Authors:  A F Strachan; E G Shephard; D U Bellstedt; G A Coetzee; D R van der Westhuyzen; F C de Beer
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

4.  Diagnosis of the type of amyloid in paraffin wax embedded tissue sections using antisera against human and animal amyloid proteins.

Authors:  C A van de Kaa; P R Hol; J Huber; R P Linke; C J Kooiker; E Gruys
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

Review 5.  Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond.

Authors:  Amy S Shah; Lirong Tan; Jason Lu Long; W Sean Davidson
Journal:  J Lipid Res       Date:  2013-02-24       Impact factor: 5.922

6.  Serum amyloid A in the mouse. Sites of uptake and mRNA expression.

Authors:  R L Meek; N Eriksen; E P Benditt
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

Review 7.  Reactive (secondary) amyloidosis and its pathogenesis.

Authors:  C P Maury
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

8.  Phosphorylation of human serum amyloid A protein by protein kinase C.

Authors:  A E Nel; M C De Beer; E G Shephard; A F Strachan; M L Vandenplas; F C De Beer
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

9.  Serum amyloid A (SAA) in viral infection: rubella, measles and subacute sclerosing panencephalitis (SSPE).

Authors:  R Shainkin-Kestenbaum; S Zimlichman; Y Winikoff; M Pras; C Chaimovitz; I Sarov
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

10.  Monoclonal hybridoma antibodies to human amyloid related protein SAA.

Authors:  G Marhaug; G Gaudernack; B Bogen; G Husby
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.